What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing by Boston Scientific is to announce and provide access to preliminary, unaudited sales results for the fourth quarter and the full fiscal year ended December 31, 2004, through a press release.

Where can I find the actual sales numbers?

The actual preliminary sales numbers are contained within the press release issued by Boston Scientific on January 10, 2005, which is attached as Exhibit 99.1 to this 8-K filing.

Are these sales figures final and audited?

No, the sales results reported in this 8-K are described as preliminary and unaudited. This means they are subject to review and potential adjustments during the company's full financial audit for the period.

Does this filing provide information on the company's profitability or net income?

This particular 8-K filing, as described, focuses specifically on sales results. It does not provide details on profitability, net income, earnings per share, or other comprehensive financial metrics. For such information, investors would need to refer to the company's subsequent quarterly or annual financial reports (like a 10-Q or 10-K).

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on January 10, 2005, to report preliminary, unaudited sales results for the fourth quarter and the full year ended December 31, 2004. This filing is primarily to furnish a press release announcing these sales figures, which are crucial for investors to assess the company's recent performance and track its progress against expectations. The information provided in this report is limited to sales results and does not include comprehensive financial statements or management commentary. Investors should refer to the furnished press release (Exhibit 99.1) for the specific sales numbers. It's important to note that these results are preliminary and unaudited, meaning they are subject to change upon completion of the full financial audit.

Key Highlights

1Boston Scientific Corporation (BSX) released preliminary, unaudited sales results for Q4 and full-year 2004.
2The filing was made on January 10, 2005, with the SEC.
3The primary purpose of the 8-K is to furnish a press release containing these sales figures.
4The press release is attached as Exhibit 99.1 to the filing.
5These are preliminary and unaudited sales results, subject to audit.
6The report does not contain detailed financial statements or management analysis beyond the sales data.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Jan 10, 2005)

Summary

Key Highlights

Frequently Asked Questions